Synapse - Howard Scher

Search Within

Howard Scher

Results (1133)

MUC-2-KLH conjugate vaccine: Immunogenicity in patients with relapsed prostate cancer

Meeting Abstract

Slovin, S. F.; Ragupathi, G.; Donaldson, C.; Olkiewicz, K.; Terry, K.; DePaolo, R.; Bauso, A.; Livingston, P. O.; Scher, H. I.
Proceedings of the American Association for Cancer Research Annual Meeting (1999)

Fulltext@MSK | Save

Detection of circulating tumor cells in prostatic carcinoma (PC) using immunobead reverse transcriptase polymerase chain reaction (RT PCR) for prostatic specific membrane antigen (PSMA) mRNA

Meeting Abstract

Ghossein, R.; Osman, I.; Bhattacharya, S.; Ferrara, J.; Fazzari, M.; Scher, H. I.
Modern Pathology (1999)

Fulltext@MSK | Save

Cellular and molecular characterization of circulating prostatic tumor cells in prostatic carcinoma patients

Meeting Abstract

Bhattacharya, S.; Scher, H. I.; Petrisco, R.; Jennings, K.; Regan, K.; Hutchinson, B.; Juan, G.; Cardon-Cardo, C.; Ghossein, R. A.
Clinical and Experimental Metastasis (1999)

Fulltext@MSK | Save

Detection of circulating tumor cells in prostatic carcinoma (PC) using immunobead reverse transcriptase polymerase chain reaction (RT PCR) for prostatic specific membrane antigen (PSMA) mRNA

Meeting Abstract

Ghossein, R.; Osman, I.; Bhattacharya, S.; Ferrara, J.; Fazzari, M.; Scher, H.
Laboratory Investigation (1999)

Fulltext@MSK | Save

Increased sensitivity in the detection of circulating prostatic tumor cells in peripheral blood after immunobead enrichment and RT-PCR for prostate specific membrane antigen (PSMA) mRNA

Meeting Abstract

Bhattacharya, S.; Osman, I.; Ferrara, J.; Scher, H. I.; Ghossein, R. A.
Journal of Histochemistry and Cytochemistry (1999)

Fulltext@MSK | Save

[F-18]2-fluoro-2-doxyglucose (FDG) and C-11-methionine (C-11 MET) positron emission tomography (PET) versus conventional imaging modalities (CIM) in patients with newly progressing metastatic prostate cancer

Meeting Abstract

Nunez, R.; Macapinlac, H.; Yeung, H. W. D.; Akhurst, T.; Finn, R. D.; Osman, I.; Petrisko, R.; Scher, H. I.; Larson, S. M.
European Journal of Nuclear Medicine (1999)

Fulltext@MSK | Save

The use of the prostate xenograft CWR22 and its androgen independent sublines in the preclinical development of herceptin

Meeting Abstract

Higgins, B.; Fox, W. D.; Maiese, K.; Fazzari, M.; Scher, H. I.; Agus, D. B.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by co-administration of ZD1839 (Iressa™), an inhibitor of EGF receptor tyrosine kinase

Meeting Abstract

Sirotnak, F. M.; Miller, V. A.; Scher, H. I.; Kris, M. G.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo

Meeting Abstract

Sirotnak, F. M.; Bornmann, W. G. B.; Miller, V. A.; Scher, H. I.; Kris, M. G.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

A phase I trial of BCL2 antisense drug G3139 (Genta, Inc.) delivered by continuous intravenous infusion alone and in combination with weekly paclitaxel

Meeting Abstract

Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Terry, K. L.; DiPaola, R. S.; Rosen, N.; Scher, H. I.
Clinical Cancer Research (1999)

Fulltext@MSK | Save